BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2004

View Archived Issues

Sinovac gains approval for clinical trial on SARS vaccine

Read More

Advanced Magnetics reports Q1 R&D highlights

Read More

Two routes of administration tested for misoprostol in the termination of early pregnancy

Read More

Aspirin and vitamin E in the prevention of cardiovascular events in type 2 diabetes

Read More

Ezetimibe reported to increase the effects of simvastatin in primary hypercholesterolemia

Read More

Lower incidence of atrial fibrillation associated with statin use in patients with chronic CAD

Read More

Finasteride superior to saw palmetto in chronic prostatitis/chronic pelvic pain syndrome

Read More

Novel porphyrins with SOD activity developed at Duke University

Read More

New 5-HT2C agonists and their use reported by Wyeth

Read More

Forbes Medi-Tech claims androstane-ascorbate conjugates in a recent patent

Read More

New antibacterial agents targeting DXP reductoisomerase claimed by Karo Bio

Read More

Sanofi-Synthelabo presents new inhibitors of neurotrophin p75 receptors

Read More

Novel inhibitors of ICAM/leukointegrin interaction under study at Boehringer Ingelheim

Read More

New p38 MAP kinase inhibitors in early development at Merck

Read More

Novel histamine H3 receptor ligands discovered by Novo Nordisk team

Read More

Chymase inhibitors prevent intraperitoneal adhesion formation in hamsters

Read More

IMMU-110 shows promising results in a B-lymphoma animal model

Read More

Epigallocatechin-3 gallate inhibits VEGF-induced angiogenesis in vitro

Read More

German approval for three-month Eligard

Read More

Biovitrum to be sole supplier of ReFacto

Read More

Ikomio ALS trial cleared to continue

Read More

Argenta enters new contract research agreement with GlaxoSmithKline

Read More

Bioequivalence demonstrated for intravenous and subcutaneous Remodulin

Read More

Zentaris and Solvay to advance LHRH antagonists through collaboration

Read More

APF-112 phase II trial progresses

Read More

Wyeth files IND for compound originating from ArQule collaboration

Read More

PDL receives licenses fees for Xolair and Raptiva

Read More

Atiprimod granted orphan drug status for multiple myeloma

Read More

Landmark year at Britannia

Read More

HemispheRx Biopharma announces joint West Nile virus clinical program

Read More

Generex Biotechnology initiates study for peri-oral delivery of Oroferone

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing